INIVATA LIMITED
ActiveCompany number 09144647
Cambridge, England · Incorporated 23 July 2014
The Glenn Berge Building, Babraham, Cambridge, CB22 3FH, England
Last updated on 2 September 2026
Research and experimental development on biotechnology · SIC 72110
Company overview
**INIVATA LIMITED** is an active private limited company incorporated on 23 July 2014 and registered in England and Wales. Its registered office is at The Glenn Berge Building, Babraham, Cambridge, CB22 3FH. The company’s principal activity is classified under SIC code 72110.
It is wholly owned by Neogenomics, Inc., which holds 75–100% of the shares and voting rights and the right to appoint and remove directors. The company has no charges, no insolvency history and has never been liquidated.
The most recent full accounts, made up to 31 December 2025, were filed on 29 July 2026. The next accounts are due by 30 September 2027. A confirmation statement was last made up to 23 July 2025.
The board currently comprises three US-resident American directors: Warren Stone (appointed 18 June 2024), Anthony P. Zook (appointed 13 May 2025) and Abhishek Jain (appointed 2 March 2026). A director was terminated on 9 March 2026.
Compliance
Financial snapshot
Detailed figures (assets, liabilities, net worth) are available in the full credit report.
Officers
No officers on record.
Persons with significant control
Funding
26 funding roundsFiling history
No filings match this type.
Risk at a glance
- Company active
- Accounts up to date
- Confirmation statement up to date
- No insolvency history
- No registered charges
- Credit score
- Recommended limit
- Payment risk
Get the complete credit report
- Detailed financial statements
- Credit score & payment risk
- CCJs, charges & insolvency checks
- Recommended credit limit
Secure checkout · Report delivered instantly